ImmunityBio shares target raised by Piper Sandler on potential approval By Investing.com
© Reuters. On Monday, Piper Sandler adjusted its price target for ImmunityBio Inc (NASDAQ:IBRX), increasing it to $5.00 from the ...
© Reuters. On Monday, Piper Sandler adjusted its price target for ImmunityBio Inc (NASDAQ:IBRX), increasing it to $5.00 from the ...
After 10 hard years of trying to get the Bitcoin ETF approved, we finally got it. It happened exactly 15 ...
In a recent shift of perspective, Bloomberg analysts have significantly lowered the forecast for the approval of a spot Ethereum ...
On Tuesday, Nexo announced its Dubai entity, Nexo DWTC, had secured preliminary approval from Dubai’s Virtual Assets Regulatory Authority (VARA) ...
© Reuters Bitcoin Price Action Explained: Here's Real Reason Why BTC Dipped After ETF Approval U.Today - 2024 has already ...
The United States Securities and Exchange Commission (SEC) Commissioner Hester Peirce, often called “Crypto Mom” for her positive stance on ...
The Securities and Exchange Commission (SEC) has revealed that the unauthorized post about approving spot Bitcoin exchange-traded funds (ETFs) on ...
© Reuters. NEW YORK - The U.S. Securities and Exchange Commission (SEC) is currently reviewing applications from two major exchange ...
olli0815/iStock Editorial via Getty Images Con Edison's (NYSE:ED) proposed $1.2B Reliable Clean City project in Queens was approved Thursday by ...
The asset management firm VanEck will close and liquidate its Bitcoin strategy exchange-traded fund, which tracks the performance of Bitcoin ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.